These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 6110459)

  • 21. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.
    Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; Ghatei MA; Bloom SR
    J Neuroendocrinol; 2000 Dec; 12(12):1213-8. PubMed ID: 11106980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inverse agonism at dopamine D2 receptors. Haloperidol-induced prolactin release from GH4C1 cells transfected with the human D2 receptor is antagonized by R(-)-n-propylnorapomorphine, raclopride, and phenoxybenzamine.
    Nilsson CL; Ekman A; Hellstrand M; Eriksson E
    Neuropsychopharmacology; 1996 Jul; 15(1):53-61. PubMed ID: 8797192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of domperidone on serum prolactin levels in human beings.
    Fujino T; Kato H; Yamashita S; Aramaki S; Morioka H; Koresawa M; Miyauchi F; Toyoshima H; Torigoe T
    Endocrinol Jpn; 1980 Aug; 27(4):521-5. PubMed ID: 7460861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of estrogen and neuroleptics on prolactin secretion and immunoreactive prolactin cells.
    Oliveira MC; Moraes JT; Barros HM; Barbosa-Coutinho LM
    Braz J Med Biol Res; 1996 Apr; 29(4):521-5. PubMed ID: 8736119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine inhibits maitotoxin-stimulated pituitary 45Ca2+ efflux and prolactin release.
    Login IS; Judd AM; MacLeod RM
    Am J Physiol; 1986 Jun; 250(6 Pt 1):E731-5. PubMed ID: 3717333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of dopamine on the altered release of prolactin, luteinizing hormone, and follicle-stimulating hormone induced by interleukin-2 in vitro.
    Karanth S; Marubayashi U; McCann SM
    Neuroendocrinology; 1992 Dec; 56(6):871-80. PubMed ID: 1369597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolactin-releasing effect of zetidoline, a new neuroleptic agent, in the rat.
    Galliani G; Restelli A; Rosina R; Glässer A
    Pharmacol Res Commun; 1984 Feb; 16(2):117-27. PubMed ID: 6150500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of prolactin release from anterior pituitary lactotrophs in culture by sulfur-containing analogs of dopamine.
    Ross PC; Burkman AM
    Proc Soc Exp Biol Med; 1988 May; 188(1):87-91. PubMed ID: 3368483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Galactogogues: medications that induce lactation.
    Gabay MP
    J Hum Lact; 2002 Aug; 18(3):274-9. PubMed ID: 12192964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of parity on pituitary prolactin response to metoclopramide and domperidone: implications for the enhancement of lactation.
    Brown TE; Fernandes PA; Grant LJ; Hutsul JA; McCoshen JA
    J Soc Gynecol Investig; 2000; 7(1):65-9. PubMed ID: 10732318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of dopamine and its antagonists on contractile activity of the lower esophageal sphincter and the stomach (author's transl)].
    Itoh Z; Aizawa I; Nakamura T
    Nihon Heikatsukin Gakkai Zasshi; 1980 Jun; 16(2):99-107. PubMed ID: 7265602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antipsychotics haloperidol and chlorpromazine increase bone metabolism and induce osteopenia in female rats.
    Kunimatsu T; Kimura J; Funabashi H; Inoue T; Seki T
    Regul Toxicol Pharmacol; 2010 Dec; 58(3):360-8. PubMed ID: 20709132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation.
    Bastianetto S; Danik M; Mennicken F; Williams S; Quirion R
    BMC Neurosci; 2006 Mar; 7():28. PubMed ID: 16573831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of corticosteroid secretion by dopaminergic mechanisms in rhesus monkeys.
    Sowers JR
    Am J Physiol; 1982 Nov; 243(5):E375-9. PubMed ID: 7137342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction in vulnerability to ventricular fibrillation by bromocriptine, a dopamine agonist.
    Falk RH; Desilva RD; Lown B
    Cardiovasc Res; 1981 Mar; 15(3):175-80. PubMed ID: 7260985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paradoxical effect of neuroleptic drugs on prolactin secretion by rat pituitary cell cultures.
    Braghiroli L; Ponzianelli A; Mazzanti G
    Life Sci; 1999; 65(14):1455-61. PubMed ID: 10530797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haloperidol causes irreversible damage to rat anterior pituitary lactotropes in culture.
    Kim KC; Burkman AM
    Res Commun Chem Pathol Pharmacol; 1982 May; 36(2):179-85. PubMed ID: 7100626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The participation of hypothalamic dopamine in morphine-induced prolactin release in man.
    Delitala G; Grossman A; Besser GM
    Clin Endocrinol (Oxf); 1983 Oct; 19(4):437-44. PubMed ID: 6627697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation by dopamine antagonists of DNA synthesis in the pituitary gland of the male rat.
    Jacobi JM; Lloyd HM
    Neuroendocrinology; 1981 Aug; 33(2):97-100. PubMed ID: 7266775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.